Avantor, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Avantor, Inc. (AVTR) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2025-02-07
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2023-03-31 was 62.90M shares, a 0.00% change year-over-year.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2022-09-30 was 0.00 shares.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2022-06-30 was 29.40M shares.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2022-03-31 was 62.90M shares.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2024 was 0.00 shares.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2022 was 22.90M shares.
- Avantor, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2021 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares 10-K · filed 2025-02-07 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2025-02-07 | |||
| 2023-03-31 | 62.90M shares 10-Q · filed 2023-04-28 | |||
| 2022-12-31 | 22.90M shares 10-K · filed 2025-02-07 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-10-27 | 30.60M shares 10-Q · filed 2023-10-27 | ||
| 2022-06-30 | 29.40M shares 10-Q · filed 2023-07-28 | 46.10M shares 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | 62.90M shares 10-Q · filed 2022-04-29 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |